Alexander Drilon and Ret - Free people check

(1 - 12 from 12

)

Cabozantinib and Cobimetinib to Be Featured in Fourteen Presentations...

ir.exelixis.com

Abstract 8007: “Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers.” Dr. Alexander Drilon , Memorial Sloan ...

The Hamoui Foundation and LUNGevity Foundation Present ...

markets.businessinsider.com

· Alexander Drilon, MD, Associate Professor, Memorial Sloan Kettering Cancer Center; Identifying non-genomic mechanisms of RET TKI resistance. Many RET-positive cancers become resistant to targeted ...

The Hamoui Foundation and LUNGevity Foundation Present ...

finance.yahoo.com

· The award has been presented to: Alexander Drilon, MD, Associate Professor, Memorial Sloan Kettering Cancer Center. Identifying non-genomic mechanisms of RET TKI resistance. Many RET-positive ...

A Phase II Study of Cabozantinib in Patients with Advanced Non-Small...

www.mskcc.org

Full Title A Phase II Study of Cabozantinib in Patients with RET Fusion-Positive Advanced Non-Small Cell Lung Cancers Purpose KIF5B/RET is an abnormal gene...

Alexander Drilon, MD [7505] - CMEducation Resources IQ&A Interactive...

www.iqanda-cme.com

What are currently the most important actionable drivers, from a mutational perspective, for lung cancer? And what is the emerging importance of RET kinase ...

Targeting ROS1, RET, and BRAF in NSCLC | OncoTherapy Network

www.cancernetwork.com

Today, we are speaking with Dr. Alexander Drilon, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City who specializes in treating...

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small...

clinicaltrials.gov

Contact: Alexander Drilon, MD United States, New York. Memorial Sloan-Kettering Cancer Center @ Suffolk, Recruiting.

'Dirtier' Drugs Step Aside in RET-Positive NSCLC | Medpage ...

www.medpagetoday.com

... advanced disease and had previously been treated with platinum-based chemotherapy, 68% responded to the investigational agent, Alexander Drilon, MD, ...

"A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET ...scholarlycommons.henryford.com › hematologyoncolo...

scholarlycommons.henryford.com

Authors. Alexander Drilon · Siqing Fu · Manish R. Patel · Marwan Fakih · Ding Wang, Henry Ford Health SystemFollow · Anthony J. Olszanski

Precision Medicine for RET Fusion–Positive NSCLC - The ...

ascopost.com

At the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC), Alexander Drilon, MD, ...

Dr. Drilon on Results of the Phase I/II LIBRETTO-001 Trial

www.onclive.com

Alexander Drilon, MD, research director, Memorial Sloan Kettering Cancer Center, discusses the results of LIBRETTO-001, a phase I/II trial of RET inhibitor,...

The Best of Philippine Speculative Fiction 2009, free to read online...

futurismic.com

“Moondown and Fugue” by Alexander Drilon “The Maiden’s Song” by Kate Aton-Osias “Capture” by Gabriela Lee “The Secret Origin of Spin-man” by Andrew Drilon

All web results to the name "Alexander Drilon"

Related search requests for Alexander Drilon

Marc Ladanyi
Neil Vasan
Ophelia Manaog

People
Forename "Alexander" (53506)
Name "Drilon" (111)

sorted by relevance / date

Advanced Search

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alexander Drilon and Ret Free People Check